Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Frontiers in Molecular Biosciences|October 9, 2020
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic CoronavirusesLuca Vangelista, Massimiliano SecchiViruses|November 11, 2022
Rational Engineering of a Sub-Picomolar HIV-1 BlockerMassimiliano Secchi, Luca VangelistaVaccine|February 5, 2008
Rational design of novel HIV-1 entry inhibitors by RANTES engineeringLuca Vangelista, Massimiliano Secchi, Paolo LussoScientific Reports|February 1, 2018
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockersMassimiliano Secchi, Valentina Grampa, Luca VangelistaProtein Expression and Purification|July 4, 2009
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutantsMassimiliano Secchi, Qiang Xu, Paolo Lusso, et al.Antimicrobial Agents and Chemotherapy|August 13, 2014
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5Massimiliano Secchi, Lia Vassena, Sébastien Morin, et al.Cancers|August 12, 2022
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network PerspectiveMassimiliano Secchi, Camilla Lodola, Anna Garbelli, et al.Journal of Virology|August 10, 2007
Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cellsMarco Patrone, Massimiliano Secchi, Eleonora Bonaparte, et al.Journal of Virology|June 16, 2005
Human cytomegalovirus UL130 protein promotes endothelial cell infection through a producer cell modification of the virionMarco Patrone, Massimiliano Secchi, Loretta Fiorina, et al.Chemistry & Biology|December 25, 2012
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptidesMassimiliano Secchi, Renato Longhi, Lia Vassena, et al.Pageof 3